The store will not work correctly when cookies are disabled.
N-(4-acetyl-5-methyl-5-(pyridin-4-yl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide
ID: ALA4293322
PubChem CID: 145987224
Max Phase: Preclinical
Molecular Formula: C12H14N4O2S
Molecular Weight: 278.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)NC1=NN(C(C)=O)C(C)(c2ccncc2)S1
Standard InChI: InChI=1S/C12H14N4O2S/c1-8(17)14-11-15-16(9(2)18)12(3,19-11)10-4-6-13-7-5-10/h4-7H,1-3H3,(H,14,15,17)
Standard InChI Key: YSVMCOKTUYMRHA-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
5.2127 -23.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6254 -22.5347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8078 -22.5301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2922 -23.0215 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.9570 -22.5461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7081 -21.7651 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8918 -21.7636 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7325 -22.8038 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3434 -22.2611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1189 -22.5187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1788 -21.4606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4147 -21.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7507 -20.3553 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6016 -21.1817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3941 -23.2331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9814 -23.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3863 -24.6493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2081 -24.6513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6171 -23.9457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 2 1 0
5 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
7 12 1 0
12 13 2 0
12 14 1 0
1 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 1 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.34 | Molecular Weight (Monoisotopic): 278.0837 | AlogP: 1.26 | #Rotatable Bonds: 1 |
Polar Surface Area: 74.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.68 | CX Basic pKa: 4.98 | CX LogP: 0.58 | CX LogD: 0.58 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.84 | Np Likeness Score: -0.68 |
References
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |